ArticleSensors (Basel, Switzerland)2022
Imtidad: A Reference Architecture and a Case Study on Developing Distributed AI Services for Skin Disease Diagnosis over Cloud, Fog and Edge.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 41 citations in OpenAlex.
- Smart IoT with the hybrid evolutionary method and image processing for tumor detection.Scientific reports · 2025Article
- Developing Smartness in Emerging Environments and Applications with a Focus on the Internet of Things.Sensors (Basel, Switzerland) · 2022Article
- LidSonic V2.0: A LiDAR and Deep-Learning-Based Green Assistive Edge Device to Enhance Mobility for the Visually Impaired.Sensors (Basel, Switzerland) · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 4 countries.
Funding
Abstract
Several factors are motivating the development of preventive, personalized, connected, virtual, and ubiquitous healthcare services. These factors include declining public health, increase in chronic diseases, an ageing population, rising healthcare costs, the need to bring intelligence near the user for privacy, security, performance, and costs reasons, as well as COVID-19. Motivated by these drivers, this paper proposes, implements, and evaluates a reference architecture called Imtidad that provides Distributed Artificial Intelligence (AI) as a Service (DAIaaS) over cloud, fog, and edge using a service catalog case study containing 22 AI skin disease diagnosis services. These services belong to four service classes that are distinguished based on software platforms (containerized gRPC, gRPC, Android, and Android Nearby) and are executed on a range of hardware platforms (Google Cloud, HP Pavilion Laptop, NVIDIA Jetson nano, Raspberry Pi Model B, Samsung Galaxy S9, and Samsung Galaxy Note 4) and four network types (Fiber, Cellular, Wi-Fi, and Bluetooth). The AI models for the diagnosis include two standard Deep Neural Networks and two Tiny AI deep models to enable their execution at the edge, trained and tested using 10,015 real-life dermatoscopic images. The services are evaluated using several benchmarks including model service value, response time, energy consumption, and network transfer time. A DL service on a local smartphone provides the best service in terms of both energy and speed, followed by a Raspberry Pi edge device and a laptop in fog. The services are designed to enable different use cases, such as patient diagnosis at home or sending diagnosis requests to travelling medical professionals through a fog device or cloud. This is the pioneering work that provides a reference architecture and such a detailed implementation and treatment of DAIaaS services, and is also expected to have an extensive impact on developing smart distributed service infrastructures for healthcare and other sectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.